title: Harmonisation of D-dimer - A call for action.
authors.affiliation: Biotherapeutics, Haemostasis Section, National Institute for Biological Standards and Control, South Mimms EN63QG, UK.
authors.forename: Colin
authors.initials: C
authors.lastname: Longstaff
authors.affiliation: Laboratory Corporation of America® Holdings, Englewood, CO, USA.
authors.forename: Dorothy
authors.initials: D
authors.lastname: Adcock
authors.affiliation: Department of Pathology, South Texas Reference Laboratories, University of Texas Health Science Center, San Antonio, TX, USA.
authors.forename: John D
authors.initials: JD
authors.lastname: Olson
authors.affiliation: United Kingdom National External Quality Assessment Scheme for Blood Coagulation (Blood Coagulation), Sheffield, UK.
authors.forename: Ian
authors.initials: I
authors.lastname: Jennings
authors.affiliation: United Kingdom National External Quality Assessment Scheme for Blood Coagulation (Blood Coagulation), Sheffield, UK.
authors.forename: Steve
authors.initials: S
authors.lastname: Kitchen
authors.affiliation: Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK.
authors.forename: Nicola
authors.initials: N
authors.lastname: Mutch
authors.affiliation: ECAT Foundation (External quality Control for Assays and Tests), The Netherlands; Diagnostic Haemostasis Laboratory, Institute of Clinical Pathology and Medical Research (ICPMR), Australia.
authors.forename: Piet
authors.initials: P
authors.lastname: Meijer
authors.affiliation: Westmead Hospital, Westmead, NSW, Australia.
authors.forename: Emmanuel J
authors.initials: EJ
authors.lastname: Favaloro
authors.affiliation: Laboratory of Clinical Chemistry and Hematology, Academic Hospital of Parma, Italy.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Lippi
authors.affiliation: Department of Haematology, Manchester Royal Infirmary, Manchester, UK. Electronic address: jecko.thachil@cmft.nhs.uk.
authors.forename: Jecko
authors.initials: J
authors.lastname: Thachil
mesh_terms: D000933:Antifibrinolytic Agents; D001774:Blood Chemical Analysis / Q000379:methods / Q000592:standards*; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis* / Q000737:chemistry; D006801:Humans; D007118:Immunoassay / Q000379:methods / Q000592:standards*; D017410:Practice Guidelines as Topic
chemical_list: D000933:Antifibrinolytic Agents; D005338:Fibrin Fibrinogen Degradation Products; C036309:fibrin fragment D